Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Multicenter, double-blind, placebo-controlled, randomized study on the efficacy and safety of ibandronate over 3 years in patients with postmenopausal osteoporosis using a continuous oral and an intermittent oral dosing regimen.
ibandronate
MF4411
osteoporosis with pathological fracture
Phase 3
 
November 2014

Powered by ideaPoint, Inc.